Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy

Cancer

Volumn 80, Issue 3, 1997, Pages 477-488

  Logsdon, Mark D ^a   Ha, Chul S ^a,c   Kavadi, Vivek S ^a,b   Cabanillas, Fernando ^a   Hess, Mark A ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Texas Cancer Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Lymphoma; Nasal cavity; Paranasal sinuses; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; CHILD; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030771278     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970801)80:3<477::AID-CNCR16>3.0.CO;2-U     Document Type: Article

References (65)

1. Fellbaum C, Hansmann M-L, Lennert K. Malignant lymphoma of the nasal cavity and paranasal sinuses. Virchows Arch A Pathol Anat Histopathol 1989;414:399-405.
2. Abbondanzo S, Wenig B. Non Hodgkin's lymphoma of the sinonasal tract. Cancer 1995;75:1281-91.
3. Frierson HF, Innes D, Mills S, Wick M. Immunophenotype analysis of sinonasal non-Hodgkin's lymphoma. Hum Pathol 1989;20:636-42.
4. Ferry J, Sklar J, Zukerberg L, Harris N. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-79.
5. Chan J, Ng C, Lau W, Lo S. Most nasal/nasopharyngeal lymphomas are peripheral T cell neoplasms. Am J Surg Pathol 1987;11:418-29.
6. Lipford EJ, Margolick J, Longo D, Fauci A, Jaffe E. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988;5: 1674-81.
7. Lippman S, Grogan T, Spier C, Koopman C, Gall E, Shimm D, et al. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59:936-40.
8. Gaulard P, Henni T, Mrolleau J, Haioun C, Henni Z, Voisin M, et al. Lethal midline granuloma (polymorphic reticulosis) and lymphogranulomatosis. Evidence for a monoclonal T-cell disorder. Cancer 1988;62:705-9.
9. Medeiros L, Peiper S, Elwood L, Yano T, Raffield M, Jaffe E. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991;22:1150-7.
10. Kanavaros P, Lescs M, Briere J, Divine M, Galateau F, Joab I, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-95.
11. Cleary K, Batsakis J. Sinonasal lymphomas. Ann Otol Rhinol Laryngol 1994;103:911-4.
12. Ho F, Todd D, Loke S, Ng R, Khoo R. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer 1984;34:143-8.
13. Ho F, Choy D, Loke S, Kung I, Fu K, Liang R, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathological study of 70 cases, and immunophenotype in 16 cases. Hum Pathol 1990;21:1041-50.
14. Ng C, Chan J, Lo S, Poon Y. Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese: a study of 75 cases in Hong Kong. Pathology 1986;18:419-25.
15. Yamanaka N, Harabuchi Y, Sambe S, Shido F, Matsuda F, Kataura A, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity, clinical and immunological aspects. Cancer 1985;56:768-76.
16. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, et al. Epstein-Barr virus in nasal T cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335:128-30.
17. Misad O, Solidoro A, Quiroz L, Olivares L. An overview of lymphoreticular malignancies in Peru. In: Magrath IT, O'Conor GT, Ramot B, editors. Pathogenesis of leukemias and lymphomas: environmental influences. New York: Raven Press, 1984;27:85-97.
18. Arber D, Weiss L, Albujar P, Chen Y, Jaffe E. Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17; 392-9.
19. Liang R, Todd D, Chan T, Chiu E, Choy D, Loke S, et al. Nasal lymphoma. A retrospective study of 60 cases. Cancer 1990;66:2205-9.
20. Liang R, Todd D, Chan T, Chiu E, Lie A, Kwong Y, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-70.
21. National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphomas. Summary and description of a Working Formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112-35.
22. Wang C. Primary malignant lymphoma of the oral cavity and paranasal sinuses. Radiology 1971;100:151-3.
23. Fletcher G. Textbook of radiotherapy. 3rd edition. Philadelphia: Lea & Febiger, 1980.
24. Ang K, Kaanders J, Peters L. Radiotherapy for head and neck cancers: indications and techniques. Philadelphia: Lea & Febiger, 1994.
25. Fuller L, Krasin M, Velasquez W, Allen P, McLaughlin P, Rodriguez M, et al. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys 1995;31:3-11.
26. Shipp M, Harrington D, Anderson J, Armitage J, Bonadonna G, Brittinger G, et al. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-94.
27. Harris E, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker, Inc., 1991.
28. Altman D. Practical statistics for medical research. London: Chapman and Hall, 1991.
29. Jiang G, Tucker S, Guttenberger R, Peters L, Morrison W, Garden A, et al. Radiation-induced injury to the visual pathway. Radiother Oncol 1994;30:17-35.
30. Frierson HJ, Mills S, Innes DJ. Non-Hodgkin's lymphomas of the sinonasal region: histologic subtypes and their clinicopathologic features. Am J Clin Pathol 1984;81:721-7.
31. Wong D, Fuller L, Butler J, Shullenberger C. Extranodal non-Hodgkin's lymphomas of the head and neck. AJR Am J Roentgenol 1975;123:471-81.
32. Robbins K, Fuller L, Vlasak M, Osborne B, Jing B, Velasquez W, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer 1985;56:814-9.
33. Jacobs C, Hoppe R. Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985;11: 357-64.
34. Burton G, Atwater S, Borowitz M, Huang A. Extranodal head an neck lymphoma: prognosis and patterns of recurrence. Arch Otolaryngol Head Neck Surg 1990;116:69-73.
35. Fu Y-S, Perzin K. Nonepithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx. Cancer 1979;43:611-21.
36. Kapidia S, Barnes L, Deutsch M. Non-Hodgkin's lymphoma of the nose and paranasal sinuses: a study of 17 cases. Head Neck Surg 1981;3:390-9.
37. Sofferman R, Cummings C. Malignant lymphoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 1975;101:287-92.
38. Mill W, Lee F, Franssila K. Radiation therapy treatment of stage I and II extranodal non-Hodkin's lymphoma of the head and neck. Cancer 1980;45:653-61.
39. Aviles A, Rodriguez L, Guzman R, Talavera A, Garcia E, Diaz-Maqueo J. Angiocentric T-cell lymphoma of the nose, paranasal sinuses, and hard palate. Hematol Oncol 1992;10:141-7.
40. Tran L, Mark R, Fu Y, Calcaterra T, Juillard G. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. Am J Clin Oncol 1992;15:222-5.
41. Chott A, Rappersberger K, Schlossarek W, Radaszkiewicz T. Peripheral T-cell lymphoma presenting as lethal midline granuloma. Hum Pathol 1988;19:1093-101.
42. Campo E, Cardesa A, Alos L, Palacin A, Cobarro J, Traserra J, et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses. An immunohistochemical study. Am J Clin Pathol 1991;96:184-90.
43. Ratech H, Burke J, Blayney DW, Sheibani K, Rappaport H. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard palate, including cases of lethal midline granuloma. Cancer 1989;64:2525-31.
44. Chan J, Ng C, Tsang W. Nasal/nasopharyngeal lymphomas: an immunohistochemical analysis of 57 cases on frozen tissues [abstract]. Mod Pathol 1993;6:87A.
45. Jaffe E. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984;2:413-26.
46. Lippman S, Miller T, Spier C, Slymen D, Grogan T. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988;72:436-41.
47. Stein R, Greer J, Flexner J, Hainsworth J, Collins R, Macon W, et al. Large-cell lymphomas: Clinical and prognostic features. J Clin Oncol 1990;8:1370-9.
48. Kondo M, Mikata A, Inuyama Y, Uematsu M, Shigematsu N, Nishiguchi I, et al. Treatment of non-Hodgkin's lymphomas in the nasal cavities and paranasal sinuses: a failure analysis. Acta Radiol Oncol 1986;25:91-7.
49. Maeda H, Aozasa K, Tsujimura T, Sasaki R, Yoshida J, Matsunaga T. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of forty-two cases with emphasis on prognostic factors. Eur J Surg Oncol 1988;14:9-15.
50. Cooper D, Ginsberg S. Brief chemotherapy, involved field radiation therapy, and central nervous system prophylaxis for paranasal sinus lymphoma. Cancer 1992;69:2888-93.
51. Cassady JR. Rhabdomyosarcoma. In: Cassady JR. Radiation therapy in pediatric oncology. Berlin: Springer-Verlag, 1994:281-304.
52. Parsons J, Bova F, Fitzgerald C, Mendenhall W, Million R. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:755-63.
53. Parsons J, Bova F, Fitzgerald C, Mendenhall W, Million R. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys 1994;30:775-80.
54. Parsons J, Bova F, Fitzgerald C, Mendenhall W, Million R. Radiation retinopathy after external irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-73.
55. Cabanillas F, Bodey G, Freireich E. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histological types. Cancer 1980;46:2356-9.
56. Miller T, Jones S. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood 1983;62:413-8.
57. Jones S, Miller T, Connors J. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiation. J Clin Oncol 1989; 7:1186-91.
58. Tsutsui K, Shibamoto Y, Yamabe H, Shim N, Dodo Y, Ono K, et al. A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma: prognostic factors and re-evaluation of treatment modality. Radiother Oncol 1991;21:83-90.
59. Itami J, Itami M, Mikata A, Tamaru J, Kaneko T, Ogata H, et al. Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 1992;20:797-802.
60. Long G, van der Pas M, Jacobs C. Combined modality treatment of non-Hodgkin's lymphoma of the paranasal sinuses [abstract]. Proc Am Soc Clin Oncol 1990;9: 264.
61. Senan S, Symonds R, Brown I. Nasal peripheral T-cell lymphoma: a 20-year review of cases treated in Scotland. Clin Oncol (R Coll Radiol) 1992;4:96-100.
62. Miller T, Dahlberg S, Cassady J, Spier C, Grogan T, Carlin S, et al. Three cycles of CHOP(3) plus radiotherapy(RT) is superior to eight cycles of CHOP(8) alone for localized intermediate and high grade non-Hodgkin's lymphoma(NHL): a Southwest Oncology Group Study. In: Perry MC, editor. Proceedings of the Thirty-Second Annual Meeting of the American Society of Clinical Oncology, Philadelphia, Pennsylvania, May 18-21, 1996.
63. Glick J, Kim K, Earle J, O'Connell M. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy(XRT) for intermediate grade early stage non-Hodgkin's lymphoma(NHL). In: Perry MC, editor. Proceedings of the Thirty-First Annual Meeting of the American Society of Clinical Oncology, Los Angeles, California, May 20-23, 1995.
64. Fisher R, Gaynor E, Dahlberg S, Oken M, Grogan T, Mize E, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002-6.
65. Gordon L, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 1992;327:1342-9.